Cancer Communications,
Год журнала:
2025,
Номер
unknown
Опубликована: Фев. 3, 2025
Abstract
Despite
significant
advancements
in
cancer
treatment,
current
therapies
often
fail
to
completely
eradicate
malignant
cells.
This
shortfall
underscores
the
urgent
need
explore
alternative
approaches
such
as
vaccines.
Leveraging
immune
system's
natural
ability
target
and
kill
cells
holds
great
therapeutic
potential.
However,
development
of
vaccines
is
hindered
by
several
challenges,
including
low
stability,
inadequate
response
activation,
immunosuppressive
tumor
microenvironment,
which
limit
their
efficacy.
Recent
progress
various
fields,
click
chemistry,
nanotechnology,
exosome
engineering,
neoantigen
design,
offer
innovative
solutions
these
challenges.
These
achievements
have
led
emergence
smart
vaccine
platforms
(SVPs),
integrate
protective
carriers
for
messenger
ribonucleic
acid
(mRNA)
with
functionalization
strategies
optimize
targeted
delivery.
Click
chemistry
further
enhances
SVP
performance
improving
encapsulation
mRNA
antigens
facilitating
precise
delivery
review
highlights
latest
developments
technologies
therapy,
exploring
both
opportunities
challenges
advancing
transformative
approaches.
Journal of Hematology & Oncology,
Год журнала:
2024,
Номер
17(1)
Опубликована: Апрель 2, 2024
Abstract
Cancer
immunotherapy
and
vaccine
development
have
significantly
improved
the
fight
against
cancers.
Despite
these
advancements,
challenges
remain,
particularly
in
clinical
delivery
of
immunomodulatory
compounds.
The
tumor
microenvironment
(TME),
comprising
macrophages,
fibroblasts,
immune
cells,
plays
a
crucial
role
response
modulation.
Nanoparticles,
engineered
to
reshape
TME,
shown
promising
results
enhancing
by
facilitating
targeted
These
nanoparticles
can
suppress
fibroblast
activation,
promote
M1
macrophage
polarization,
aid
dendritic
cell
maturation,
encourage
T
infiltration.
Biomimetic
further
enhance
increasing
internalization
agents
cells
such
as
cells.
Moreover,
exosomes,
whether
naturally
secreted
body
or
bioengineered,
been
explored
regulate
TME
immune-related
affect
cancer
immunotherapy.
Stimuli-responsive
nanocarriers,
activated
pH,
redox,
light
conditions,
exhibit
potential
accelerate
co-application
with
checkpoint
inhibitors
is
an
emerging
strategy
boost
anti-tumor
immunity.
With
their
ability
induce
long-term
immunity,
nanoarchitectures
are
structures
development.
This
review
underscores
critical
overcoming
current
driving
advancement
modification.
Advanced Materials,
Год журнала:
2023,
Номер
36(9)
Опубликована: Ноя. 6, 2023
The
recent
prevalence
of
monkeypox
has
led
to
the
declaration
a
Public
Health
Emergency
International
Concern.
Monkeypox
lesions
are
typically
ulcers
or
pustules
(containing
high
titers
replication-competent
virus)
in
skin
and
mucous
membranes,
which
allow
virus
transmit
predominantly
through
intimate
contact.
Currently,
effective
clinical
treatments
for
lacking,
strategies
blocking
transmission
fraught
with
drawbacks.
Herein,
this
work
constructs
biomimetic
nanotemplate
(termed
TBD@M
NPs)
macrophage
membranes
as
coat
polymeric
nanoparticles
loading
versatile
aggregation-induced
emission
featured
photothermal
molecule
TPE-BT-DPTQ
core.
In
surrogate
mouse
model
(vaccinia-virus-infected
tail
scarification
model),
intravenously
injected
NPs
show
precise
tracking
near-infrared
region
II
fluorescence
imaging
lesions.
Upon
808
nm
laser
irradiation,
is
eliminated
by
effect
infected
wound
heals
rapidly.
More
importantly,
inoculation
treated
lesion
tissue
suspensions
does
not
trigger
infection
inflammatory
activation
healthy
mice,
indicating
successful
blockage
transmission.
This
study
demonstrates
first
time
theranostics
using
nanomedicine,
may
bring
new
insight
into
development
viable
strategy
management
trials.
The
advent
of
immunotherapy
has
revolutionized
the
treating
modalities
cancer.
Cancer
vaccine,
aiming
to
harness
host
immune
system
induce
a
tumor-specific
killing
effect,
holds
great
promises
for
its
broad
patient
coverage,
high
safety,
and
combination
potentials.
Despite
promising,
clinical
translation
cancer
vaccines
faces
obstacles
including
lack
potency,
limited
options
tumor
antigens
adjuvants,
immunosuppressive
microenvironment.
Biomimetic
bioinspired
nanotechnology
provides
new
impetus
designing
concepts
vaccines.
Through
mimicking
stealth
coating,
pathogen
recognition
pattern,
tissue
tropism
pathogen,
other
irreplaceable
properties
from
nature,
biomimetic
could
gain
functions
such
as
longstanding,
targeting,
self-adjuvanting,
on-demand
cargo
release.
specific
behavior
endogenous
molecules
each
type
living
entity
(cell
or
microorganism)
offer
unique
features
address
needs
immunotherapy.
In
this
review,
strategies
inspired
by
eukaryotic
cells,
bacteria,
viruses
will
be
overviewed
advancing
vaccine
development.
Our
insights
into
future
development
shared
at
end
expediting
translation.
Journal of Nanobiotechnology,
Год журнала:
2024,
Номер
22(1)
Опубликована: Янв. 3, 2024
Abstract
Exosomes
are
nanoscale
extracellular
vesicles
secreted
by
cells
and
enclosed
a
lipid
bilayer
membrane
containing
various
biologically
active
cargoes
such
as
proteins,
lipids,
nucleic
acids.
Engineered
exosomes
generated
through
genetic
modification
of
parent
show
promise
drug
delivery
vehicles,
they
have
been
demonstrated
to
great
therapeutic
potential
for
treating
cancer,
cardiovascular,
neurological,
immune
diseases,
but
systematic
knowledge
is
lacking
regarding
optimization
loading
assessment
efficacy.
This
review
summarizes
current
approaches
engineering
evaluating
their
effects,
techniques
assessing
exosome
release
kinetics,
cell
targeting,
biodistribution,
pharmacokinetics,
outcomes
critically
examined.
Additionally,
this
synthesizes
the
latest
applications
in
clinical
translation.
The
compiled
provides
framework
rational
design
rigorous
therapeutics.
Continued
advancement
robust
characterization
methods
reporting
standards
will
accelerate
development
technologies
pave
way
studies.
Graphical
Journal of Nanobiotechnology,
Год журнала:
2025,
Номер
23(1)
Опубликована: Янв. 22, 2025
Photoimmunotherapy,
which
combines
phototherapy
with
immunotherapy,
exhibits
significantly
improved
therapeutic
effects
compared
mono-treatment
regimens.
However,
its
use
is
associated
drawbacks,
such
as
insufficient
reactive
oxygen
species
(ROS)
production
and
uneven
photosensitizer
distribution.
To
address
these
issues,
we
developed
a
controllable,
targeted
nanosystem
that
enhances
oxidative
stress
through
multiple
pathways,
achieving
synergistic
photothermal,
photodynamic,
immunotherapy
for
tumor
treatment.
These
nanoparticles
(D/I@HST
NPs)
accurately
target
overexpressed
transferrin
receptors
(TfRs)
on
the
surface
of
cells
surface-modified
(Tf).
After
endocytosis,
D/I@HST
NPs
generate
ROS
under
808-nm
laser
irradiation,
breaking
ROS-responsive
crosslinking
agent
increasing
drug
release
utilization.
Tf
also
carries
Fe3+,
reduced
to
Fe2+
by
iron
reductase
in
acidic
microenvironment
(TME).
Consequently,
endoperoxide
bridge
structure
dihydroartemisinin
cleaved,
causing
additional
generation.
Furthermore,
released
IR-780
exerts
both
photodynamic
photothermal
effects,
enhancing
cell
death.
This
multi-pathway
amplification
effect
can
trigger
immunogenic
death
tumors,
promoting
relevant
antigens
damage-associated
molecular
patterns,
thereby
dendritic
maturation
sensitivity
immunotherapy.
Mature
transmit
signals
T
cells,
infiltration
activation,
facilitating
growth
inhibition
suppression
lung
metastasis.
myeloid-derived
suppressor
decreases
after
In
summary,
this
stress-amplified
effectively
inhibits
reverses
immunosuppressive
microenvironment,
provides
new
insights
into
combined
phototherapy.
Advanced Materials,
Год журнала:
2023,
Номер
36(6)
Опубликована: Сен. 19, 2023
Abstract
Compared
to
injection
administration,
oral
administration
is
free
of
discomfort,
wound
infection,
and
complications
has
a
higher
compliance
rate
for
patients
with
diverse
diseases.
However,
reduces
the
bioavailability
medicines,
especially
biologics
(e.g.,
peptides,
proteins,
antibodies),
due
harsh
gastrointestinal
biological
barriers.
In
this
context,
development
prosperity
nanotechnology
have
helped
improve
bioactivity
availability
medicines.
On
basis,
first,
barriers
are
discussed,
then
nanomedicine
based
on
organic
inorganic
nanomaterials
their
biomedical
applications
in
diseases
reviewed.
Finally,
challenges
potential
opportunities
future
nanomedicine,
which
may
provide
vital
reference
eventual
clinical
transformation
standardized
production
put
forward.
Advanced NanoBiomed Research,
Год журнала:
2024,
Номер
4(8)
Опубликована: Май 31, 2024
Immune
dysregulation
is
a
pivotal
factor
in
the
onset
and
progression
of
various
diseases.
In
cancer,
immune
system's
inability
to
discern
eliminate
abnormal
cells
leads
uncontrolled
tumor
growth.
When
faced
with
resilient
pathogens
or
harmful
toxins,
system
encounters
challenges
clearance
neutralization.
Achieving
delicate
balance
pro‐inflammatory
anti‐inflammatory
signals
essential
managing
range
disorders
Like
other
biomedical
research
domains,
nanotechnology
has
provided
innovative
approaches
for
rebalancing
host
immunity.
Among
plethora
nanotechnology‐based
interventions,
concept
cell
membrane‐coated
nanoparticles
holds
significant
potential
immunomodulatory
applications
owing
their
biomimetic
properties
that
allow
precise
interaction
compromised
system.
This
review
thoroughly
examines
novel
nanosystems
modulation.
The
exploration
covers
crucial
elements,
including
origins
characteristics
membranes,
methods
employed
procurement
coating,
physicochemical/biological
characterization
techniques,
enhancement
therapeutic
efficacy
via
functionalization.
Subsequently,
case
studies‐based
analysis
utilizing
these
bioinspired
tackling
different
conditions
caused
by
disturbance
been
comprehensively
discussed.
Advanced Functional Materials,
Год журнала:
2024,
Номер
34(30)
Опубликована: Апрель 9, 2024
Abstract
Limited
ability
to
elicit
cellular
immune
responses
has
restricted
the
effectiveness
of
conventional
adjuvants
in
context
cancers.
Recent
advancements
innate
activation
mechanism
investigations
have
paved
way
for
implementation
a
“bottom‐up”
approach
development
novel
adjuvants.
Herein,
simple
hydrogel
adjuvant
with
uniformly
organized
nanoscale
microstructure,
termed
MnP
gel
is
devised,
by
employing
self‐assembling
peptides
incorporated
manganese
ions
(Mn
2+
).
exhibits
Mn
sustained‐release
properties
vivo
and
effectively
promotes
germinal
center
formation,
thereby
facilitating
generation
antibodies
at
levels
comparable
aluminum‐based
Moreover,
transcends
scope
humoral
immunity,
demonstrating
robustly
trigger
positioning
it
as
promising
candidate
cancer
prevention
treatments.
In
conclusion,
work
introduced
well‐defined
proof‐of‐concept,
simplifying
vaccine
design
opening
up
new
avenues
“on‐demand”
immunomodulation
strategies.